Relmada Therapeutics financial statements

렐마다 테라퓨틱스NASDAQ:RLMD · Nasdaq · Healthcare · sector #17
$3.25-0.91%
2026-10-07 close

Relmada Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$84M.

Reported results

Relmada Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy